Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SLC16A3 | O15427 | 3/20 | 0.38 |
| ▸ | SLC16A1 | P53985 | 3/20 | 0.38 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2231637 | 1.00 | KDM4E (0.39) | KDM4ELMNAPKMKMT2ASLC16A3 | |
| SCHEMBL20395654 | 0.87 | SLC16A3 (0.33) | KDM4ELMNAPKMKMT2ASLC16A3 | |
| SCHEMBL21248116 | 0.87 | KDM4E (0.36) | KDM4ELMNAPKMKMT2ASLC16A3 | |
| SCHEMBL1275703 | 0.82 | KDM4E (0.37) | KDM4ELMNAPKMKMT2ASLC16A3 | |
| SCHEMBL28712283 | 0.79 | KDM4E (0.35) | KDM4ELMNAPKMKMT2ASLC16A3 | |
| SCHEMBL450204 | 0.79 | CYP2C9 (0.38) | KDM4ELMNAPKMKMT2ASLC16A3 | |
| SCHEMBL15441 | 0.79 | KDM4E (0.42) | KDM4ELMNAPKMKMT2ASLC16A3 | |
| SCHEMBL22246044 | 0.79 | KDM4E (0.42) | KDM4ELMNAPKMKMT2ASLC16A3 | |
| SCHEMBL15440 | 0.79 | KDM4E (0.42) | KDM4ELMNAPKMKMT2ASLC16A3 | |
| SCHEMBL11051248 | 0.77 | KDM4E (0.41) | KDM4ELMNAPKMKMT2ASLC16A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11897978-B2 | Hybrid light-curing composition | DYMAX CORPORATION (US) | 2024-02-13 | — | — | US | claimed |
| US-20210301045-A1 | HYBRID LIGHT-CURING COMPOSITION | DYMAX CORPORATION | 2021-09-30 | — | — | US | claimed |
| US-9550883-B2 | Cyanoacrylate compositions | Henkel IP & Holding GmbH (DE) | 2017-01-24 | — | — | US | claimed |
| US-20140326407-A1 | CYANOACRYLATE COMPOSITIONS | Henkel US IP LLC (US) | 2014-11-06 | — | — | US | claimed |
| EP-0963420-B1 | RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS | HENKEL LOCTITE CORP (US) | 2007-04-25 | — | — | EP | claimed |
| US-7064155-B2 | Luminescing and/or fluorescing radiation-curable, cyanoacrylate-containing compositions | HENKEL CORPORATION (US) | 2006-06-20 | — | — | US | claimed |
| US-6906112-B1 | Radiation-curable, cyanoacrylate-containing compositions | HENKEL CORPORATION (US) | 2005-06-14 | — | — | US | claimed |
| US-6867241-B2 | Radiation-curable, cyanoacrylate-containing compositions | HENKEL CORPORATION (US) | 2005-03-15 | — | — | US | claimed |
| US-6726795-B1 | COMPOSITION COMPRISING 2-CYANOACRYLATE MONOMER, METALLOCENE, PHOTOINITIATOR, SULFUR-CONTAINING COMPOUND, AND POLYMETHYL METHACRYLATE | Henkel IP & Holding GmbH (DE) | 2004-04-27 | — | — | US | claimed |
| US-20040034116-A1 | Luminescing and/or fluorescing radiation-curable, cyanoacrylate-containing compositions | HENKEL LOCTITE CORPORATION | 2004-02-19 | — | — | US | claimed |
| US-20030162857-A1 | Radiation-curable, cyanoacrylate-containing compositions | LOCTITE CORPORATION | 2003-08-28 | — | — | US | claimed |
| WO-2003065841-A1 | LUMINESCING AND/OR FLUORESCING RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS | HENKEL CORPORATION (US) | 2003-08-14 | — | — | WO | claimed |
| WO-2003064483-A1 | RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS | HENKEL CORPORATION (US) | 2003-08-07 | — | — | WO | claimed |
| EP-0963420-A4 | RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS | LOCTITE CORP (US) | 2003-01-15 | — | — | EP | claimed |
| US-6433036-B1 | METALLOCENE AND PHOTOINITIATOR; EXPOSURE TO ELECTROMAGNETIC RADIATION | LOCTITE CORPORATION | 2002-08-13 | — | — | US | claimed |
| EP-0963420-A1 | RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS | LOCTITE CORPORATION (US) | 1999-12-15 | — | — | EP | claimed |
| WO-1998038260-A9 | RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS | — | 1999-02-11 | — | — | WO | claimed |
| WO-1998038260-A1 | RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS | LOCTITE CORPORATION (US) | 1998-09-03 | — | — | WO | claimed |
| EP-4331796-A1 | ACTINIC RADIATION CURABLE CYANOACRYLATE COMPOSITIONS FOR CERAMICS AND INVESTMENT CASTING | ARKEMA FRANCE (FR) | 2024-03-06 | — | — | EP | disclosed |
| WO-1998038260-A1 | RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS | LOCTITE CORPORATION (US) | 1998-09-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210301045-A1 | HYBRID LIGHT-CURING COMPOSITION | MUS81, MAT2B, MAT1A | KDM4E 1835/4885LMNA 1479/4885PKM 3482/4885 |
| US-11897978-B2 | Hybrid light-curing composition | MUS81, MAT2B, MAT1A | KDM4E 1835/4885LMNA 1479/4885PKM 3482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.